Kinetics of Extracellular Vesicles in Hemodialysis

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

November 7, 2023

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
End-stage Kidney Disease
Interventions
DEVICE

Routine hemodialysis

"* Dialyzers: Cordiax FX80 dialyzers; membrane material HelixonePlus (polysulfone); (Fresenius Medical Care Bad Homburg, Germany)~* Dialysis machines: Baxter Gambro AK 98 (Gambro Lundia AB, Lund, Sweden; part of Baxter Healthcare Corporation)~* Needles for vascular access: Nipro SafeTouch dialysis cath 1.6x25 mm (16G) or 1.9x25 mm (15G); or Nipro SafeTouch Tulip needles (15G; all Nipro Medical Europe Mechelen, Belgium)~* Ultrapure dialysis fluids (less than 0.1 colony forming units/ml, less than 0.03 endotoxin units/ml) will be mixed with AC-F 219/1 or 213/4 liquid acid concentrates and BiBag dry bicarbonate concentrate. Hence, the electrolyte composition of the dialysis fluid will be: Na 138-142 mmol/L; K 2.0-3.0 mmol/L; HCO3 26-35 mmol/L; Ca 1.25-1.50 mmol/L; Mg 0.5 mmol/L; Cl 108.5-109 mmol/L; glucose 5.6 mmol/L; acetate 3 mmol/L. Dialysate flow rate will be 500 mL/min.~* Anticoagulation: nadroparin."

Trial Locations (1)

1105AZ

Dianet Amsterdam, Amsterdam

All Listed Sponsors
collaborator

Dianet Dialysis Centers

OTHER

lead

Amsterdam UMC, location VUmc

OTHER

NCT05957146 - Kinetics of Extracellular Vesicles in Hemodialysis | Biotech Hunter | Biotech Hunter